« Previous
Next »
European Journal of Cancer
Volume 46, Issue 9
, Pages 1661-1667
, June 2010
Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis
References
- . Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell Biochem. 2004;266:37–56
- . Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS. 2007;115:81–103
- Response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 2002;277:19396–19401
- . The thioredoxin system in cancer. Semin. Cancer Biol. 2006;16:420–426
- . DNA adduct 8-hydroxydeoxiguanosine, a novel putative marker of prognostic significance in ovarian carcinoma. Int. J. Gynecol. Cancer. 2009;19:1047–1051
- . Tumours of the breast and female genital organs. Lyon: IARC Press, WHO; 2003;
- . Biochemistry of oxidative stress. Biochem. Soc. Trans. 2007;35:1147–1150
- . Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 2004;567:1–61
- . 8-Hydroxy-2′-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer. 2007;109:574–580
- Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett. 2008;259:218–230
- Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic. Biol. Med. 1999;27:401–410
- . Increasing oxidative damage and loss of mismatch repair enzymes during breast carcinogenesis. Eur. J. Cancer. 2006;42:2653–2659
- Prognostic significance of iNOS in epithelial ovarian cancer. Gynecol. Oncol. 2007;105:97–103
- Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome. Gynecol. Oncol. 2004;92:806–812
- . Stress-induced peroxiredoxins. Subcell. Biochem. 2007;44:375–384
- Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defense and tumor suppression. Nature. 2003;424:561–565
- Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. APMIS. 2004;112:123–132
PII: S0959-8049(10)00109-7
doi: 10.1016/j.ejca.2010.02.006
© 2010 Elsevier Ltd. All rights reserved.
« Previous
Next »
European Journal of Cancer
Volume 46, Issue 9
, Pages 1661-1667
, June 2010
